Genome International Biomedical Co. Ltd filed its Annual on Mar 31, 2014 for the period ending Dec 31, 2013. In this report its auditor, Ernst & Young LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
23.35 TWD | -1.48% | -2.30% | -32.12% |
1st Jan change | Capi. | |
---|---|---|
-32.12% | 31.81M | |
-1.52% | 24.18B | |
+3.42% | 8.46B | |
+8.55% | 8.34B | |
-23.71% | 7.64B | |
+13.68% | 5.33B | |
+1.31% | 4.12B | |
-6.90% | 3.92B | |
+5.56% | 3.89B | |
+18.80% | 3.54B |
- Stock Market
- Equities
- 6130 Stock
- News Shangya Technology Co., Ltd.
- Genome International Biomedical Co. Ltd Auditor Raises 'Going Concern' Doubt